EDGAR Filing Documents for 0001415889-15-003742

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001415889-15-003742

Filing Date

2015-11-16

Accepted

2015-11-16 16:08:06

Documents

Period of Report

2015-09-30

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-Q	ecte10q_sep302015.htm	10-Q	590146
2	CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE	ex31-1.htm	EX-31.1	11331
3	CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE	ex31-2.htm	EX-31.2	11212
4	CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1	ex32-1.htm	EX-32.1	5268
5	CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1	ex32-2.htm	EX-32.2	5347
	Complete submission text file	0001415889-15-003742.txt		2762236

Data Files

Seq	Description	Document	Type	Size
6	XBRL INSTANCE DOCUMENT	ecte-20150930.xml	EX-101.INS	326746
7	XBRL TAXONOMY EXTENSION SCHEMA	ecte-20150930.xsd	EX-101.SCH	42959
8	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	ecte-20150930_cal.xml	EX-101.CAL	41509
9	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	ecte-20150930_def.xml	EX-101.DEF	127571
10	XBRL TAXONOMY EXTENSION LABEL LINKBASE	ecte-20150930_lab.xml	EX-101.LAB	271932
11	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	ecte-20150930_pre.xml	EX-101.PRE	212249

Mailing Address 99 WOOD AVENUE SOUTH SUITE 302 ISELIN NJ 08830

Business Address 99 WOOD AVENUE SOUTH SUITE 302 ISELIN NJ 08830 732-549-0919

Echo Therapeutics, Inc. (Filer) CIK: 0001031927 (see all company filings)